报价延迟最少15分钟:2025/09/01 13:21 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.41 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.53/--
|
|
企业价值
13.45M
|
| 资产负债 |
|
每股账面净值
-0.65
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/09/01 13:21 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and providethe necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. |
